Margo A Vick, LCSW in Provo, UT - Counselor

Margo A Vick, LCSW is a Counselor based in Provo, Utah. Margo A Vick is licensed to practice in Utah (license number 6000385-3501) and her current practice location is 1300 E Center St, Provo, Utah. She can be reached at her office (for appointments etc.) via phone at (801) 344-4400.

NPI number for Margo A Vick is 1316132426 and her current mailing address is 1300 E Center St, Provo, Utah. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1316132426.

Contact Information

	Margo A Vick, LCSW
	1300 E Center St, Provo, UT 84606-3554
	(801) 344-4400
	(801) 344-4225

Healthcare Provider's Profile

Full Name	Margo A Vick
Gender	Female
Speciality	Counselor
Location	1300 E Center St, Provo, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1316132426
Provider Enumeration Date: 09/11/2007
Last Update Date: 02/09/2023

Medical Identifiers

Medical identifiers for Margo A Vick such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316132426	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	6000385-3502 (Utah)	Secondary
101Y00000X	Counselor	6000385-3501 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Margo A Vick is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Margo A Vick, LCSW 1300 E Center St, Provo, UT 84606-3554 Ph: (801) 344-4400	Margo A Vick, LCSW 1300 E Center St, Provo, UT 84606-3554 Ph: (801) 344-4400

News Archive

C-Path receives FDA contract to develop clinical outcome assessments for pediatric asthma

The Critical Path Institute announced today it has been awarded a U.S. Food and Drug Administration contract in support of ongoing development of novel clinical outcome assessments for pediatric asthma.

Lung transplants for cystic fibrosis may not be such a good option

Researchers in the United States say lung transplants do little to improve the outcomes for children with severe cystic fibrosis (CF) and often increases their risk of dying.

New discovery could help improve some forms of chemotherapy

The research looked at XPB helicase from an archaea, a single cell organism similar to bacteria. Helicases are enzymes that unwind or separate the strands of the nucleic acid double helix, an action that is critical to transcription and nucleotide excision repair (NER), as well as other cell processes.

Government health IT advisers examine privacy policies

One of the latest hurdles government advisers helping to shape health information technology policy must jump is addressing the amount of control patients should have over their own records, Modern Healthcare reports.

New network aims to develop innovative treatments and devices for children

For a variety of reasons, medications and devices specifically developed for children have traditionally lagged behind similar products for adults. A new federally funded program intends to address these unmet medical needs by improving quality and efficiency in developing innovative pediatric medicines and devices.

Margo A Vick, LCSW - in Provo, UT